Solco Healthcare US Announces the FDA Approval for its generic to Hyzaar® Tablets

CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Hyzaar® Tablets (Losartan Potassium and Hydrochlorothiazide tablets), 50-12.5mg, 100-12.5mg and 100-25mg.  The product is available now.

Losartan Potassium-HCTZ is used to treat high blood pressure (hypertension). It is also used to lower the risk of stroke in certain people with heart disease.

“We are pleased to receive this FDA approval, which rounds out our Losartan Potassium product family,” said Hai Wang, President of Solco Healthcare.

According to IQVIA, U.S. brand and generic sales of Losartan Potassium-HCTZ tablets were approximately $54.5 million for the 12 months ending in December 2017.